Activation of the EGF receptor (EGF-R) plays a key role in the proliferation and invasion of prostate cancer and therefore constitutes a pathologically relevant factor for analysis of prostate cancer growth in the 22Rv1 model [24]. The gene discussed is EGFR; the disease is prostate carcinoma.